Preview

User

Not a user? Register with this site Forgot your password?

Modern Rheumatology Journal

Advanced search
Fullscreen

For citations:

Vasilenko EA, Samigullina RR, Karibova AK, Grabovetskaya YY, Mazurov VI. Efficacy and safety of 24-week therapy with a monoclonal antibody to TRBV9+ T lymphocytes (seniprutug) in patients with ankylosing spondylitis: real-world data. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2025;19(5):62-68. (In Russ.) https://doi.org/10.14412/1996-7012-2025-5-62-68

Views PDF (Rus): 4


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)

"IMA-PRESS" LLC 
115093, Russian Federation, Moscow,
Partijnyj per, 1, bld. 58, of. 745
E-mail: info@ima-press.net
Phone: +7(495) 926-7814

Processing of personal data
supported by NEICON (Elpub lab)